Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Lilly weight-loss drug copycats dealt blow
Hims & Hers Health stock tanks after FDA says competitor Eli Lilly’s weight-loss drug shortage is over
The San Francisco telehealth company had capitalized on the shortage by making copycat versions of popular brand-name GLP-1 medications.
Eli Lilly’s Weight-Loss, Diabetes Drug Shortages Are Over, FDA Says
The removal of Zepbound and Mounjaro from the regulator’s shortage list could lead to restrictions on pharmacies making custom-made versions.
Eli Lilly’s weight-loss drug no longer in shortage, FDA says
The two-year shortage of Eli Lilly’s blockbuster weight-loss and diabetes drugs is over, the U.S. Food and Drug Administration announced Wednesday.
Lilly, Indiana
Eli Lilly to Invest $4.5B for New Manufacturing & Research Plant
The Medicine Foundry, which is expected to create 400 jobs, will be situated in the LEAP Research and Innovation District in Lebanon, Indiana. Lilly has already made significant investments in Lebanon,
Eli Lilly announces additional $4.5 billion investment into central Indiana LEAP District
Eli Lilly announced Wednesday it will invest another $4.5 billion into a new facility at the states controversial LEAP District in central Indiana.
Eli Lilly to build $4.5 billion Indiana facility for advanced drug manufacturing
Eli Lilly said Wednesday it will invest $4.5 billion to build an advanced pharmaceutical drug manufacturing and development facility in Lebanon, Indiana expected to open in late 2027.
13h
Eli Lilly, Moderna and more: The 5 highest paid healthcare CEOs
Health care stocks underperformed the broader market in 2023, with many companies falling short of their profit targets, and ...
7h
Eli Lilly & Co (LLY) Gets a Buy from Truist Financial
In a report released today, Srikripa Devarakonda from Truist Financial reiterated a Buy rating on Eli Lilly & Co (LLY – Research ...
1d
Drugmaker Lilly slates another $4.5B for manufacturing and drug development improvements
Lilly will add the center to a site in Lebanon, Indiana, where it is already spending about $9 billion to improve ...
1d
Lilly investing $4.5 billion for ‘first of its kind’ medicine foundry in Lebanon
Eli Lilly and Company will invest an additional $4.5 billion in Boone County to create a new center for advanced ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Related topics
Indiana
Zepbound
Mounjaro
Hims
Food and Drug Administration
Feedback